FANIA, Liliana
FANIA, Liliana
Advanced cutaneous squamous cell carcinoma. biology, immunotherapy, and evolving prognostic factors
2025 Di Guardo, A; Trovato, F; Cantisani, C; Ricci, F; Di Lella, G; Moro, F; Morese, R; Panebianco, A; Nisticò, Sp; Pellacani, G; Fania, L.
Cutaneous leishmaniasis of the nose evaluated with confocal microscopy successfully treated with topical 5% imiquimod
2026 Di Guardo, A.; Didona, B.; Ambrosio, L.; Ricci, F.; Panebianco, A.; Di Lella, G.; Abeni, D.; Fania, L.
Non-Invasive Assessment of Treatment Response in Actinic Keratosis: A Clinically Oriented Multimodal Review
2026 Pistore, G.; Ambrosio, L.; Di Guardo, A.; Panebianco, A. R.; Di Lella, G.; Conforti, C.; Pellacani, G.; Moro, F.; Marchetti, P.; Abeni, D.; Fania, L.; Ricci, F.
Similar levels of efficacy of two different maintenance doses of adalimumab on clinical severity and quality of life of patients with hidradenitis suppurativa
2022 Fania, L; Giovanardi, G; Samela, T; Caposiena, D; Chiricozzi, A; Antonelli, F; Saraceni, P; Elia, F; Garcovich, S; Ciccone, D; Cannizzaro, Mv; Miraglia, E; Iacovino, C; Giustini, S; Skroza, N; Mambrin, A; Potenza, C; Bianchi, L; Peris, K; Abeni, D.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Advanced cutaneous squamous cell carcinoma. biology, immunotherapy, and evolving prognostic factors | 2025 | Di Guardo, A; Trovato, F; Cantisani, C; Ricci, F; Di Lella, G; Moro, F; Morese, R; Panebianco, A; Nisticò, Sp; Pellacani, G; Fania, L. | |
| Cutaneous leishmaniasis of the nose evaluated with confocal microscopy successfully treated with topical 5% imiquimod | 2026 | Di Guardo, A.; Didona, B.; Ambrosio, L.; Ricci, F.; Panebianco, A.; Di Lella, G.; Abeni, D.; Fania, L. | |
| Non-Invasive Assessment of Treatment Response in Actinic Keratosis: A Clinically Oriented Multimodal Review | 2026 | Pistore, G.; Ambrosio, L.; Di Guardo, A.; Panebianco, A. R.; Di Lella, G.; Conforti, C.; Pellacani, G.; Moro, F.; Marchetti, P.; Abeni, D.; Fania, L.; Ricci, F. | |
| Similar levels of efficacy of two different maintenance doses of adalimumab on clinical severity and quality of life of patients with hidradenitis suppurativa | 2022 | Fania, L; Giovanardi, G; Samela, T; Caposiena, D; Chiricozzi, A; Antonelli, F; Saraceni, P; Elia, F; Garcovich, S; Ciccone, D; Cannizzaro, Mv; Miraglia, E; Iacovino, C; Giustini, S; Skroza, N; Mambrin, A; Potenza, C; Bianchi, L; Peris, K; Abeni, D. |